- mental health
- learning disabilities
To reinforce our collective efforts in these areas, independent panels have been established.
2017/18 assessments for cancer and maternity
See below for the commentary by the independent panels, assessment methodology and CCG ratings.
2016/17 assessments for cancer, mental health, dementia and diabetes
Assessments of progress in 2016/17 have been made in the following clinical priority areas:
This document sets out the methodologies used in the 2016/17 CCG assessments for cancer, mental health, dementia and diabetes.
- View the methodologies used for the 2016/17 assessments of cancer, mental health, dementia and diabetes
See below for commentaries on the 2016/17 ratings for:
These were prepared by the respective independent panel chairs: Sir Harpul Kumar, Chief Executive, Cancer Research UK, Sir Paul Farmer, Chief Executive of Mind; Jeremy Hughes, Chief Executive of the Alzheimer’s Society; and, Chris Askew, Chief Executive of Diabetes UK.
Improvement and support offers
The improvement and support offers to help CCGs improve their performance in each of the clinical priority areas are listed below: